MARYANNE GALLAGHER: Open Payments
NPI 1992253629 · WILLIAMSTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 61 payments from 24 companies in 2025. Trend: 2023 $1,125 · 2024 $1,115 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $170 |
| PFIZER INC. | 6 | $98 |
| Axsome Therapeutics, Inc. | 3 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| Lilly USA, LLC | 4 | $71 |
| Amgen Inc. | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Abbott Laboratories | 2 | $48 |
| Exact Sciences Corporation | 2 | $44 |
Products named: Ozempic, Auvelity, Kerendia, REXULTI, MOUNJARO, JARDIANCE, Rybelsus, FREESTYLE LIBRE 3.
Industry payments across NJ — which companies pay providers there.
